Human Pluripotent Stem Cell Functional Identification Kit

Newer Version Available: SC027B

Discontinued Product

SC027 has been discontinued and is replaced by SC027B.

Product Details
Procedure
Citations (12)
FAQs
Reviews

Human Pluripotent Stem Cell Functional Identification Kit Summary

Kit Summary

To verify pluripotency in human stem cells by
in vitro functional differentiation.

Key Benefits

  • Verifies the pluripotency of your starting population
  • Only takes 5 days
  • Reduces experimental variation
 

Why functionally verify human stem cell pluripotency in vitro?

To determine if a cell is truly a pluripotent stem cell, it is important to verify its ability to differentiate into each of the three germ layers. See Details

The teratoma assay is a standard way to assess pluripotency, but this method requires expensive animal models and is time-consuming, often requiring 6 to 10 weeks before pluripotency status can be determined. Similarly, embryoid body assays are time-consuming and rely on random differentiation.

  • Uses fully defined supplements to drive reproducible differentiation.
  • Provides results in 5 days to save time and reagents.
  • Avoids tissue embedding and sectioning procedures.
  • Can verify the ability to differentiate into 3 germ layers without the use of an animal model.
  • Verifies a healthy, pluripotent starting stem cell population to increase consistency between studies and reduce unwanted experimental variability.

Kit Contents

This kit contains the following specially formulated media supplements and growth factors to drive pluripotent stem cell differentiation and a marker to characterize each of the three germ layer cell types.

  • Differentiation Base Media Supplement (50X)
  • Ectoderm, Mesoderm, and Endoderm Differentiation Supplements
  • Ectoderm Marker: Goat Anti-Human Otx2 Antigen Affinity-purified Polyclonal Antibody
  • Mesoderm Marker: Goat Anti-Human Brachyury Antigen Affinity-purified Polyclonal AntibodyV
  • Endoderm Marker: Goat Anti-Human SOX17 Antigen Affinity-purified Polyclonal Antibody

The quantity of each component in this kit is sufficient to make 200 mL of media for differentiation. This is enough media for the differentiation of one 24-well plate of each cell type.

The acute and chronic effects of over-exposure to the reagents in this kit are unknown. Safe laboratory handling procedures should be followed and protective clothing should be worn when handling kit reagents.

 

Stability and Storage

Store at -20° C in a manual defrost freezer. This kit is stable for up to 6 months from the date of receipt.

Data Examples

Verification of Induced Pluripotent Stem Cell Pluripotency.
View Larger Image

Verification of Induced Pluripotent Stem Cell Pluripotency.iPS2 human induced pluripotent stem cells were differentiated to ectoderm, mesoderm, and endoderm using the media supplements included in the Human Pluripotent Stem Cell Functional Identification Kit (Catalog # SC027). The kit also contains Goat Anti-Human Otx2 (ectoderm), Goat Anti-Human Brachyury (mesoderm), and Goat Anti-Human SOX17 (endoderm) Antigen Affinity-purified Polyclonal Antibodies for the confirmation of differentiation status. To further evaluate lineage commitment, cells were stained with a Goat Anti-Human SOX1 Antigen Affinity-purified Antibody (Catalog # AF3369), a Goat Anti-Human HAND1 Antigen Affinity-purified Antibody (Catalog # AF3168), and a Goat Anti-Human HNF-3 beta/FoxA2 Antigen Affinity-purified Antibody (Catalog # AF2400). The cells were stained using the NorthernLights™ 557-conjugated Donkey Anti-Goat IgG Secondary Antibody (Catalog # NL001; red) and the nuclei were counterstained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Cells on Coverslips.

Verification of Human Embryonic Stem Cell Pluripotency.
View Larger Image

Verification of Human Embryonic Stem Cell Pluripotency.BG01V human embryonic stem cells were differentiated to ectoderm, mesoderm, and endoderm using the media supplements included in the Human Pluripotent Stem Cell Functional Identification Kit (Catalog # SC027). The kit also contains Goat Anti-Human Otx2 (ectoderm), Goat Anti-Human Brachyury (mesoderm), and Goat Anti-Human SOX17 (endoderm) Antigen Affinity-purified Polyclonal Antibodies for the confirmation of differentiation status. The cells were stained using the NorthernLights™ 557-conjugated Donkey Anti-Goat IgG Secondary Antibody (Catalog # NL001; red) and the nuclei were counterstained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Cells on Coverslips.

Product Datasheets

Preparation and Storage

Stability & Storage
Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.

Background: Pluripotent Stem Cells

Embryonic stem (ES) cells are pluripotent stem cells derived from the inner cell mass of pre-implantation embryos. Induced pluripotent stem (iPS) cells can be generated by somatic cell reprogramming following the exogenous expression of specific transcription factors (Oct-3/4, KLF4, SOX2, and c-Myc). These cell types are capable of unlimited, undifferentiated proliferation in vitro and still maintain the capacity to differentiate into a wide variety of somatic cells. In this capacity, pluripotent stem cells have widespread clinical potential for the treatments of heart disease, diabetes, spinal cord injury, and a variety of neurodegenerative disorders.

R&D Systems offers a wide range of products to support pluripotent stem cell culture and differentiation. Mouse embryonic fibroblasts may be used to maintain and expand pluripotent stem cells in an undifferentiated state. We also offer defined culture media, which are specifically optimized for use with human or rodent pluripotent stem cells. In addition, R&D Systems offers a variety of products to assess differentiation status and identify specific stem cell types of interest, including panels of marker antibodies, primer pairs, multi-color flow cytometry kits, and specialized verification kits.

Alternate Names
Pluripotent Stem Cells

Assay Procedure

Refer to the productdatasheet for complete product details.

 

Briefly, the pluripotency status of human stem cells is verified using the following in vitro
differentiation procedure:

  • Culture pluripotent cells of interest
  • Induce endoderm, mesoderm, and ectoderm differentiation with media supplements
  • Evaluate differentiation using germ layer markers and fluorescent ICC
 

Reagents Provided

 

Kit Components

Reagents supplied in the Human Pluripotent Stem Cell Functional Identification Kit (Catalog # SC027):

  • Differentiation Base Media Supplement (50X)
  • Ectoderm Differentiation Supplement
  • Mesoderm Differentiation Supplement
  • Endoderm Differentiation Supplement I
  • Endoderm Differentiation Supplement II
  • Ectoderm Marker: Goat Anti-Human Otx2 Antigen Affinity-purified Polyclonal Antibody
  • Mesoderm Marker: Goat Anti-Human Brachyury Antigen Affinity-purified Polyclonal Antibody
  • Endoderm Marker: Goat Anti-Human SOX17 Antigen Affinity-purified Polyclonal Antibody
     

    Note: The quantity of each component in this kit is sufficient to make 200 mL of medium for differentiation. This is enough medium for the differentiation of one 24-well plate for each lineage.

Other Supplies Required

Reagents

  • RPMI
  • BSA, very low endotoxin
  • D-MEM/F-12 (1X)
  • GlutaMAX™ (Invitrogen or equivalent)
  • Penicillin-Streptomycin
  • Phosphate Buffered Saline (PBS)
  • Trypan Blue Solution
  • MEF Conditioned Media (Catalog # AR005 or equivalent)
  • StemXVivo™ Culture Matrix (100X) (Catalog # CCM013), Cultrex® PathClear® BME Reduced Growth Factor Basement Membrane Extract (Catalog # 3433-005-01), or equivalent
  • Recombinant Human FGF basic (Tissue culture grade; Catalog # 4114-TC or equivalent)
  • Accutase® (Innovative Cell Technologies or equivalent)

Materials

  • Human pluripotent stem cells
  • 24-well culture plates
  • 15 mL centrifuge tubes
  • 50 mL centrifuge tubes
  • 0.2 μm syringe filter
  • 10 mL syringe
  • Pipettes and pipette tips
  • Serological pipettes

Equipment

  • 37 °C and 5% CO2 incubator
  • Centrifuge
  • Hemocytometer
  • Inverted microscope
  • 37 °C water bath

Procedure Overview

This protocol is designed for BG01V human embryonic stem (hES) cells and iPS2 human induced pluripotent stem (iPS) cells grown in Mouse Embryonic Fibroblast (MEF) Conditioned Media (Catalog # AR005). If using different cell lines or growth media, this protocol may need to be optimized.

Note: The quality of the human pluripotent cells used in the differentiation is imperative. Use of suboptimal quality or very high passage pluripotent cells can result in decreased differentiation efficiency and/or increased cell death.

 

Undifferentiated Cell Preparation

Add 1:100 Culture Matrix or Cultrex BME in sterile PBS.

Culture Matrix or Cultrex BME in sterile PBS

 

 

Add 1.1x105 cells/cm2 in MEF Conditioned Media containing 4 ng/mL FGF Basic.

MEF Conditioned Media containing 4 ng/mL FGF Basic

 

Differentiation Procedures

 

Ectoderm
Differentiation

Mesoderm
Differentiation

Endoderm
Differentiation

Day 1 Replace media with
Ectoderm Differentiation Media.
Replace media with
Mesoderm Differentiation Media.
Replace media with
Endoderm Differentiation Media.
Day 2 Repeat

Repeat media change 12-16 hours later.
ICC detection of Brachyury (24-36 hours after initial differentiation)

16-24 hours later, Replace media with Endoderm Differentiation Media II.
Day 3 Repeat   Replace media with Endoderm Differentiation Media II.
Day 4 ICC detection of Otx2.   ICC detection of SOX17.

Citations for Human Pluripotent Stem Cell Functional Identification Kit

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

12 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL
    Authors: AL Gagne, JA Maguire, S Gandre-Bab, ST Chou, SK Tasian, ML Loh, MJ Weiss, P Gadue, DL French
    Stem Cell Res, 2018;31(0):157-160.  2018
  2. Atorvastatin Inhibits the HIF1?-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells
    Authors: Y Nakashima, C Miyagi-Shi, H Noguchi, T Omasa
    Mol. Ther., 2018;0(0):.  2018
  3. Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration
    Authors: Y Nam, YA Rim, SM Jung, JH Ju
    Stem Cell Res Ther, 2017;8(1):16.  2017
  4. Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes
    Authors: T Shinozawa, K Nakamura, M Shoji, M Morita, M Kimura, H Furukawa, H Ueda, M Shiramoto, K Matsuguma, Y Kaji, I Ikushima, M Yono, SY Liou, H Nagai, A Nakanishi, K Yamamoto, S Izumo
    Stem Cell Reports, 2017;0(0):.  2017
  5. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology
    Authors: Glenda M Halliday
    Acta Neuropathol., 2016;0(0):.  2016
  6. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade
    Authors: Claudia Altomare
    Europace, 2016;18(0):iv67-iv76.  2016
  7. The Generation of Human Induced Pluripotent Stem Cells from Blood Cells: An Efficient Protocol Using Serial Plating of Reprogrammed Cells by Centrifugation
    Stem Cells Int, 2016;2016(0):1329459.  2016
  8. Cholesterol-secreting and statin-responsive hepatocytes from human ES and iPS cells to model hepatic involvement in cardiovascular health.
    Authors: Krueger, Winfried, Tanasijevic, Borko, Barber, Vanessa, Flamier, Anthony, Gu, Xinsheng, Manautou, Jose, Rasmussen, Theodore
    PLoS ONE, 2013;8(7):e67296.  2013
  9. Characteristics of bovine inner cell mass-derived cell lines and their fate in chimeric conceptuses.
    Authors: Furusawa, Tadashi, Ohkoshi, Katsuhir, Kimura, Koji, Matsuyama, Shuichi, Akagi, Satoshi, Kaneda, Masahiro, Ikeda, Mitsumi, Hosoe, Misa, Kizaki, Keiichir, Tokunaga, Tomoyuki
    Biol Reprod, 2013;89(2):28.  2013
  10. Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood.
    Authors: Szablowska-Gadomska, Ilona, Sypecka, Joanna, Zayat, Valery, Podobinska, Martyna, Pastwinska, Anna, Pienkowska-Grela, Barbara, Buzanska, Leonora
    Acta Neurobiol Exp (Wars), 2012;72(4):337-50.  2012
  11. Cellular Phenotypes in Human iPSC-Derived Neurons from a Genetic Model of Autism Spectrum Disorder.
    Authors: Deshpande A, Yadav S, Dao D, Wu Z, Hokanson K, Cahill M, Wiita A, Jan Y, Ullian E, Weiss L
    Cell Rep, 0;21(10):2678-2687.  0
  12. Inducible overexpression of RUNX1b/c in human embryonic stem cells blocks early hematopoiesis from mesoderm.
    Authors: Chen B, Teng J, Liu H, Pan X, Zhou Y, Huang S, Lai M, Bian G, Mao B, Sun W, Zhou Q, Yang S, Nakahata T, Ma F
    J Mol Cell Biol, 0;9(4):262-273.  0

FAQs

No product specific FAQs exist for this product, however you may

View all Stem Cell Product FAQs

Reviews for Human Pluripotent Stem Cell Functional Identification Kit

There are currently no reviews for this product. Be the first to review Human Pluripotent Stem Cell Functional Identification Kit and earn rewards!

Have you used Human Pluripotent Stem Cell Functional Identification Kit?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review